$SSKN
STRATA Skin Sciences, Inc.

2022 Q4 Form 10-Q Financial Statement

#000114036122040727 Filed on November 09, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $10.60M $9.413M $7.711M
YoY Change 17.06% 22.07% 37.38%
Cost Of Revenue $3.754M $3.614M $2.335M
YoY Change 22.8% 54.78% -2.01%
Gross Profit $6.848M $5.799M $5.376M
YoY Change 14.13% 7.87% 66.44%
Gross Profit Margin 64.59% 61.61% 69.72%
Selling, General & Admin $6.273M $6.369M $5.470M
YoY Change -1.15% 16.44% 37.44%
% of Gross Profit 91.6% 109.83% 101.75%
Research & Development $441.0K $216.0K $371.0K
YoY Change 59.78% -41.78% -9.73%
% of Gross Profit 6.44% 3.72% 6.9%
Depreciation & Amortization $3.477M $592.0K $575.0K
YoY Change 232.09% 2.96% 26.65%
% of Gross Profit 50.77% 10.21% 10.7%
Operating Expenses $6.714M $6.585M $5.841M
YoY Change 1.39% 12.74% 33.02%
Operating Profit $134.0K -$786.0K -$465.0K
YoY Change -121.54% 69.03% -59.95%
Interest Expense -$231.0K $244.0K -$52.00K
YoY Change 12.14% -569.23% 160.0%
% of Operating Profit -172.39%
Other Income/Expense, Net -$209.0K -$52.00K
YoY Change 301.92% 147.62%
Pretax Income -$97.00K -$995.0K -$517.0K
YoY Change -88.27% 92.46% -56.26%
Income Tax $63.00K $0.00 $4.000K
% Of Pretax Income
Net Earnings -$160.0K -$995.0K -$521.0K
YoY Change -81.15% 90.98% -58.45%
Net Earnings / Revenue -1.51% -10.57% -6.76%
Basic Earnings Per Share -$0.03 -$0.02
Diluted Earnings Per Share $0.00 -$0.03 -$15.26K
COMMON SHARES
Basic Shares Outstanding 34.72M 34.72M 34.02M
Diluted Shares Outstanding 34.72M 34.15M

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.434M $7.454M $13.05M
YoY Change -56.83% -42.87% 17.97%
Cash & Equivalents $5.434M $7.454M $13.05M
Short-Term Investments
Other Short-Term Assets $2.052M $1.982M $623.0K
YoY Change 344.16% 218.14% -92.07%
Inventory $5.547M $5.662M $3.225M
Prepaid Expenses
Receivables $4.471M $3.655M $3.151M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $17.50M $18.75M $20.05M
YoY Change -12.35% -6.45% -19.61%
LONG-TERM ASSETS
Property, Plant & Equipment $7.498M $6.566M $6.403M
YoY Change 8.94% 2.55% 21.78%
Goodwill $8.803M $8.803M
YoY Change 0.0%
Intangibles $17.39M $18.11M
YoY Change 72.51%
Long-Term Investments
YoY Change
Other Assets $98.00K $167.0K $233.0K
YoY Change -54.63% -28.33% -21.81%
Total Long-Term Assets $34.77M $34.48M $26.71M
YoY Change 30.59% 29.09% 20.72%
TOTAL ASSETS
Total Short-Term Assets $17.50M $18.75M $20.05M
Total Long-Term Assets $34.77M $34.48M $26.71M
Total Assets $52.27M $53.24M $46.76M
YoY Change 12.19% 13.85% -0.65%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.425M $4.369M $2.480M
YoY Change 21.37% 76.17% -28.9%
Accrued Expenses $6.555M $6.075M $5.548M
YoY Change 2.79% 9.5% 21.72%
Deferred Revenue $2.778M $2.968M
YoY Change -15.43%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $0.00
YoY Change -100.0%
Total Short-Term Liabilities $13.43M $14.16M $12.15M
YoY Change 4.87% 16.49% -34.94%
LONG-TERM LIABILITIES
Long-Term Debt $7.476M $7.435M $7.282M
YoY Change 2.15% 2.1% 422.38%
Other Long-Term Liabilities $9.233M $9.576M $873.0K
YoY Change 1065.78% 996.91% 1578.85%
Total Long-Term Liabilities $7.476M $7.435M $8.155M
YoY Change 2.15% -8.83% 463.97%
TOTAL LIABILITIES
Total Short-Term Liabilities $13.43M $14.16M $12.15M
Total Long-Term Liabilities $7.476M $7.435M $8.155M
Total Liabilities $30.44M $31.44M $20.58M
YoY Change 43.73% 52.78% -2.66%
SHAREHOLDERS EQUITY
Retained Earnings -$227.2M -$227.1M
YoY Change 2.5%
Common Stock $35.00K $35.00K
YoY Change 2.94%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $21.83M $21.80M $26.18M
YoY Change
Total Liabilities & Shareholders Equity $52.27M $53.24M $46.76M
YoY Change 12.19% 13.85% -0.65%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$160.0K -$995.0K -$521.0K
YoY Change -81.15% 90.98% -58.45%
Depreciation, Depletion And Amortization $3.477M $592.0K $575.0K
YoY Change 232.09% 2.96% 26.65%
Cash From Operating Activities -$5.000K -$694.0K $452.0K
YoY Change -100.75% -253.54% -17.82%
INVESTING ACTIVITIES
Capital Expenditures $1.515M -$527.0K -$1.057M
YoY Change -234.07% -50.14% 46.81%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 -$3.473M
YoY Change -100.0%
Cash From Investing Activities -$1.515M -$527.0K -$4.530M
YoY Change 34.07% -88.37% 529.17%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -500.0K 0.000 92.00K
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -5.000K -694.0K 452.0K
Cash From Investing Activities -1.515M -527.0K -4.530M
Cash From Financing Activities -500.0K 0.000 92.00K
Net Change In Cash -2.020M -1.221M -3.986M
YoY Change 338.18% -69.37% 2244.71%
FREE CASH FLOW
Cash From Operating Activities -$5.000K -$694.0K $452.0K
Capital Expenditures $1.515M -$527.0K -$1.057M
Free Cash Flow -$1.520M -$167.0K $1.509M
YoY Change -184.49% -111.07% 18.82%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
25414000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
2028000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5389000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1845000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12000
CY2022Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
500000
CY2021Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0
CY2021Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div><span style="font-family: 'Times New Roman';"> </span> <span style="font-family: 'Times New Roman';"> </span></div> <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: italic; font-variant: normal; text-transform: none;"><span style="font-weight: bold;">Reclassifications</span></div> <div><span style="font-family: 'Times New Roman';"> </span></div> <div><span style="font-family: 'Times New Roman';"> </span></div> <div style="text-align: justify;"><span style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">Certain reclassifications from the prior year presentation have been made to conform to the current year presentation. These reclassifications did not have a material impact on the Company’s condensed consolidated financial position, results of operations, or cash flows.</span><span style="font-family: 'Times New Roman';"><br/> </span> </div>
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4482012
CY2022Q3 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P36M
CY2022Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
583000
CY2022Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
358000
CY2022Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2022Q3 sskn Contract With Customer Liability Current Advance Consideration
ContractWithCustomerLiabilityCurrentAdvanceConsideration
358000
CY2022Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
225000
CY2022Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
152000
CY2021Q3 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
19000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
790000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
73000
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
34723046
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
0-51481
dei Entity Registrant Name
EntityRegistrantName
STRATA SKIN SCIENCES, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
13-3986004
dei Entity Address Address Line1
EntityAddressAddressLine1
5 Walnut Grove Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 140
dei Entity Address City Or Town
EntityAddressCityOrTown
Horsham
dei Entity Address State Or Province
EntityAddressStateOrProvince
PA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
19044
dei City Area Code
CityAreaCode
215
dei Local Phone Number
LocalPhoneNumber
619-3200
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
dei Trading Symbol
TradingSymbol
SSKN
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001051514
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-995000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-517000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1113000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
455000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-995000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
21800000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-521000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
26183000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1816000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1576000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
320000
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0
CY2021Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
585000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2155000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
2028000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
12000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
8000000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
133000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
7275000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
500000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
92000
sskn Change In Operating Lease Right Of Use Assets And Liability Due To Amended Lease
ChangeInOperatingLeaseRightOfUseAssetsAndLiabilityDueToAmendedLease
446000
sskn Change In Operating Lease Right Of Use Assets And Liability Due To Amended Lease
ChangeInOperatingLeaseRightOfUseAssetsAndLiabilityDueToAmendedLease
0
sskn Warrants Issued
WarrantsIssued
0
sskn Warrants Issued
WarrantsIssued
585000
sskn Assumed Deferred Revenue
AssumedDeferredRevenue
0
sskn Assumed Deferred Revenue
AssumedDeferredRevenue
1841000
us-gaap Use Of Estimates
UseOfEstimates
<div><span style="font-family: 'Times New Roman';"> </span> <span style="font-family: 'Times New Roman';"> </span></div> <div style="text-align: justify; font-style: italic; font-weight: bold; font-family: 'Times New Roman'; font-size: 10pt; color: rgb(0, 0, 0); font-variant: normal; text-transform: none;">Use of Estimates</div> <div><span style="font-family: 'Times New Roman';"> </span></div> <div><span style="font-family: 'Times New Roman';"> </span></div> <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt; font-weight: normal; color: rgb(0, 0, 0); font-variant: normal; text-transform: none; font-style: normal;"><span style="font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">The preparation of the co<span style="background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">ndensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect amounts reported of assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting periods. Actual results could differ from those estimates and be based on events different from those assumptions. As of September </span>30, 2022, the more significant estimates include revenue recognition with respect to deferred revenues and the contract term and valuation allowances of accounts receivable, inputs used when evaluating goodwill for impairment, inputs used in the valuation of acquired intangible assets, state sales and tax accruals, the estimated useful lives of intangible assets, and the valuation allowance related to deferred tax assets.</span></div>
CY2022Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
1361000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5196344
CY2022Q3 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
5426000
CY2021Q4 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
3201000
CY2022Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
236000
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
288000
CY2022Q3 us-gaap Inventory Net
InventoryNet
5662000
CY2021Q4 us-gaap Inventory Net
InventoryNet
3489000
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
27968000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
26654000
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
21402000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
19771000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6566000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6883000
CY2022Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
592000
CY2021Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
575000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1816000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1576000
CY2022Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
31596000
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
13486000
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
18110000
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
21414000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
11331000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
10083000
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
719000
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
408000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2155000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1113000
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2022Q3 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2021Q3 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
717000
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
2871000
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2871000
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2166000
CY2022Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
1461000
CY2022Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
118000
CY2021Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
59000
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1379000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2052000
CY2022Q3 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
3742000
CY2021Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
3697000
CY2022Q3 sskn Accrued Professional Fees Other Accrued Liabilities
AccruedProfessionalFeesOtherAccruedLiabilities
836000
CY2021Q4 sskn Accrued Professional Fees Other Accrued Liabilities
AccruedProfessionalFeesOtherAccruedLiabilities
569000
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6075000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
6377000
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
1000000
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
4000000
CY2022Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
3000000
CY2022Q3 us-gaap Long Term Debt
LongTermDebt
8000000
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
455000
CY2021Q3 us-gaap Share Based Compensation
ShareBasedCompensation
320000
us-gaap Share Based Compensation
ShareBasedCompensation
1275000
us-gaap Share Based Compensation
ShareBasedCompensation
1563000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.896
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.025
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y1M6D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost
173000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-517000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9413000
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
3614000
CY2022Q3 us-gaap Gross Profit
GrossProfit
5799000
CY2022Q3 sskn Percentage Of Gross Profit
PercentageOfGrossProfit
0.616
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
216000
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3754000
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2615000
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
6585000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-786000
CY2022Q3 us-gaap Interest Expense
InterestExpense
244000
CY2022Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
35000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-995000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25559000
us-gaap Cost Of Revenue
CostOfRevenue
10639000
us-gaap Gross Profit
GrossProfit
14920000
sskn Percentage Of Gross Profit
PercentageOfGrossProfit
0.584
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
588000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
11516000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7599000
us-gaap Costs And Expenses
CostsAndExpenses
19703000
us-gaap Operating Income Loss
OperatingIncomeLoss
-4783000
us-gaap Interest Expense
InterestExpense
651000
us-gaap Investment Income Interest
InvestmentIncomeInterest
45000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5389000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7711000
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
2335000
CY2021Q3 us-gaap Gross Profit
GrossProfit
5376000
CY2021Q3 sskn Percentage Of Gross Profit
PercentageOfGrossProfit
0.697
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
371000
CY2021Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3295000
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2175000
CY2021Q3 us-gaap Costs And Expenses
CostsAndExpenses
5841000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-465000
CY2021Q3 us-gaap Interest Expense
InterestExpense
53000
CY2021Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
1000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
20920000
us-gaap Cost Of Revenue
CostOfRevenue
7070000
us-gaap Gross Profit
GrossProfit
13850000
sskn Percentage Of Gross Profit
PercentageOfGrossProfit
0.662
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1158000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9387000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7085000
us-gaap Costs And Expenses
CostsAndExpenses
17630000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9413000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25559000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7711000
us-gaap Operating Income Loss
OperatingIncomeLoss
-3780000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
2028000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
20920000
us-gaap Interest Expense
InterestExpense
109000
us-gaap Investment Income Interest
InvestmentIncomeInterest
16000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1845000
sskn Change In Operating Lease Right Of Use Assets And Liability Due To Amended Lease
ChangeInOperatingLeaseRightOfUseAssetsAndLiabilityDueToAmendedLease
446000
sskn Change In Operating Lease Right Of Use Assets And Liability Due To Amended Lease
ChangeInOperatingLeaseRightOfUseAssetsAndLiabilityDueToAmendedLease
0
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
86000
CY2021Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
108000
us-gaap Operating Lease Cost
OperatingLeaseCost
298000
us-gaap Operating Lease Cost
OperatingLeaseCost
331000
CY2022Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
93000
CY2021Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
113000
us-gaap Operating Lease Payments
OperatingLeasePayments
320000
us-gaap Operating Lease Payments
OperatingLeasePayments
344000
sskn Operating Lease Incremental Borrowing Rate Percent
OperatingLeaseIncrementalBorrowingRatePercent
0.0891
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
98000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
369000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
328000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
146000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
76000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1017000
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
97000
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
920000
sskn Development Agreement Term
DevelopmentAgreementTerm
P3Y

Files In Submission

Name View Source Status
sskn-20220930_cal.xml Edgar Link unprocessable
0001140361-22-040727-index-headers.html Edgar Link pending
0001140361-22-040727-index.html Edgar Link pending
0001140361-22-040727.txt Edgar Link pending
0001140361-22-040727-xbrl.zip Edgar Link pending
brhc10043798_10q.htm Edgar Link pending
brhc10043798_ex31-1.htm Edgar Link pending
brhc10043798_ex31-2.htm Edgar Link pending
brhc10043798_ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image00001.jpg Edgar Link pending
image1.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
brhc10043798_10q_htm.xml Edgar Link completed
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
sskn-20220930.xsd Edgar Link pending
sskn-20220930_def.xml Edgar Link unprocessable
sskn-20220930_lab.xml Edgar Link unprocessable
sskn-20220930_pre.xml Edgar Link unprocessable